Results 241 to 250 of about 18,452 (302)

Management of Pulmonary Arterial Hypertension: Current Strategies and Future Prospects. [PDF]

Life (Basel)
Sharma M, Paudyal V, Syed SK, Thapa R, Kassam N, Surani S.   +5 more
europepmc   +1 more source

Kinetics of endothelin-1 and effect selective ET_A antagonism on ET_B activation: a mathematical modeling analysis. [PDF]

Front Pharmacol
Hallow KM, Greasley PJ, Heerspink HJL, Yu H.   +3 more
europepmc   +1 more source

Fundamental and Targeted Approaches in Pulmonary Arterial Hypertension Treatment. [PDF]

Pharmaceutics
Park JS, Choi YH, Min JY, Lee J, Shim G.
europepmc   +1 more source

Unmasking the relationship between CGRP and glutamate: from peripheral excitation to central sensitization in migraine. [PDF]

J Headache Pain
Martami F, Holton KF.
europepmc   +1 more source

Treatment Patterns of Patients With Pulmonary Hypertension: A Descriptive Study in Colombia. [PDF]

Clin Respir J
Machado-Duque M, Gaviria-Mendoza A, Valladales-Restrepo LF, Pacheco M, Franco JS, Del Rosario Forero M, Suarez R, Peñuela O, Machado-Alba JE.   +8 more
europepmc   +1 more source

Efficacy and safety of endothelin A receptor antagonists in IgA nephropathy: a systematic review and meta-analysis. [PDF]

Clin Kidney J
Tian Z, Yang Y, Mei J, Huang M, Li Y, Fang Z, Li Y, Tang L, Li Y.   +8 more
europepmc   +1 more source

Macitentan for Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Pulmonary Vascular Disease: Results of the SERENADE Randomized Clinical Trial and Open-Label Extension Study. [PDF]

Circ Heart Fail
Shah SJ, Bonderman D, Borlaug BA, Cleland JGF, Lack G, Lu W, Voors AA, Zannad F, Gladwin MT.   +8 more
europepmc   +1 more source